Clearance of Mycoplasma ovipneumoniae in Captive Bighorn Sheep (Ovis canadensis) Following Extended Oral Doxycycline Treatment

J Wildl Dis. 2023 Oct 1;59(4):753-758. doi: 10.7589/JWD-D-22-00094.

Abstract

Respiratory disease is a significant barrier for bighorn sheep (Ovis canadensis) conservation, and a need remains for management options in both captive and free-ranging populations. We treated Mycoplasma ovipneumoniae infection in six bighorn lambs and five bighorn yearlings at two captive research facilities with twice daily oral doxycycline for 8 wk or longer. Doses of 5 mg/kg twice daily mixed in formula for lambs and 10 mg/kg twice daily mixed in moistened pellets for older lambs and yearlings were tolerated well with minimal side effects. All animals in this case report remain Mycoplasma ovipneumoniae free over 2 yr later. Further evaluation is warranted to confirm efficacy of this therapeutic approach.

Keywords: Mycoplasma ovipneumoniae; Ovis canadensis; Bighorn sheep; doxycycline; pasteurella; respiratory disease.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Doxycycline / therapeutic use
  • Mycoplasma ovipneumoniae*
  • Pneumonia, Mycoplasma* / drug therapy
  • Pneumonia, Mycoplasma* / veterinary
  • Sheep
  • Sheep Diseases* / drug therapy
  • Sheep, Bighorn*

Substances

  • Doxycycline